Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434121 · ClinicalTrials.gov registry record · Phase 1
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01434121 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 24 participants.
The verdict
NCT01434121, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The major goal of this project is to determine whether intravenously infused ascorbic acid is safe for use as a viable therapeutic strategy in adult humans with sepsis.
Interventions
- DRUG Placebo
- DRUG Ascorbic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01434121
The ClinicalTrials.gov registry entry for NCT01434121 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01434121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01434121 about?
NCT01434121 is a clinical study titled "Ascorbic Acid (Vitamin C) Infusion in Human Sepsis". The major goal of this project is to determine whether intravenously infused ascorbic acid is safe for use as a viable therapeutic strategy in adult humans with sepsis.
What is the current status of trial NCT01434121?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2010-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01434121?
The interventions under investigation include: Placebo (DRUG), Ascorbic Acid (DRUG).
Who is sponsoring clinical trial NCT01434121?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.